ABSTRACT
Targeted therapeutics for SARS-CoV-2 virus caused COVID-19 are in urgent need. Chansu has been reported to have broad-spectrum antiviral effects and widely used in Southeast Asian countries. This study aims to assess the efficacy of Chansu injection in treating patients with severe COVID-19. A randomized preliminary clinical trial was conducted and eligible patients were allocated to receive general treatment plus Chansu injection or only general treatment as control for 7 days. The primary outcomes of the oxygenation index PaO2/FiO2 and ROX, secondary outcomes of white blood cell count, respiratory support step-down time (RSST), safety indicators, etc were monitored. After 7 days of treatment, the oxygenation index was improved in 95.2% patients in the treatment group compared with 68.4% in the control group. The PaO2/FiO2 and ROX indices in the treatment group (mean, 226.27+/-67.35 and 14.01+/-3.99 respectively) were significantly higher than the control group (mean, 143.23+/-51.29 and 9.64+/-5.54 respectively). The RSST was 1 day shorter in the treatment group. Multivariate regression analysis suggested that Chansu injection contributed the most to the outcome of PaO2/FiO2. No obvious adverse effects were observed. The preliminary data showed that Chansu injection had apparent efficacy in improving the respiratory function of patients with severe COVID-19.Copyright © 2021 The Authors
ABSTRACT
Because of the impact of the COVID-19 pandemic, more and more people are choosing to buy food online, including eggs. Although this mode of shopping is very modern, many Chinese consumers lack scientific knowledge when selecting eggs. In this study, we used the multivariate statistical analysis and sensory analysis to evaluate and compare the qualities of online sale of free-range and cage eggs. How feeding conditions influence the quality of eggs and how physical characteristics influence the price of eggs were also studied in this work. Our research showed that there is a lack of scientific support for distinguish free-range eggs from cage eggs on the appearance, the color of the yolk does not represent the amount of protein in yolk which may actually be affected by fodders. Moreover, the nutritional quality of free-range eggs is no better than that of cage eggs. Sensory analysis showed that free-range eggs taste better, which is likely because of the higher yolk ratio. Multivariate linear regression analysis showed that Rearing systems, fodder type and yolk color have significant impact on the price (Price = 0.428 × Rearing system −0.235 × Fodder type + 0.191 × Yolk color). © 2023, Sociedade Brasileira de Ciencia e Tecnologia de Alimentos, SBCTA. All rights reserved.
ABSTRACT
Background: Severe COVID-19 is associated with platelet activation, thrombosis, and thrombocytopenia, but the mechanisms remain unclear. Similarly, very rare cases of COVID-19 vaccine-induced-thrombotic-thrombocytopenia (VITT) are also poorly understood. Both infection and vaccination utilize the receptor-binding domain (RBD) of the spike protein for virus-host cell entry and to elicit an immune response, respectively. Interestingly, the RBD contains an RGD integrin-binding motif that may facilitate platelet binding. Aim(s): To determine whether the RBD binds platelets and causes platelet activation/clearance. Method(s): We intravenously injected different doses (0.25, 0.5, 1.0mug/g) of recombinant RBD into mice and measured platelet counts post-injection using a Z2 Series Coulter. Flow cytometry detected RBD/RBD variants binding to platelets and associated platelet activation, apoptosis, and desialylation. Human gel-filtered platelet aggregation was induced by ADP, Collagen and Thrombin. Six anti-RBD monoclonal antibodies (mAbs) were generated and tested in a SARS-CoV-2 Vero cell infection model with the envelop gene quantified by RT-qPCR to determine the virus replication. Result(s): RBD injection caused platelet clearance in a dose-dependent manner. The RBD could also bind to platelets, induce activation and potentiate platelet aggregation in vitro. Our preliminary data also showed the RBD Delta variant has greater potential in inducing platelet activation. Interestingly, the RBD bound beta3-/-platelets ~50% less relative than wildtype mice. Consistently, mutating the RGD motif to RGE, and preincubating platelets with the beta3 inhibitor Eptifibatide also reduced RBD binding to platelets. Our novel anti-RBD mAbs 4F2 and 4H12 inhibited RBD-induced platelet activation and RBD-potentiated platelet aggregation in vitro, and prevented RBD-induced platelet clearance in vivo. Importantly, these mAbs also inhibited SARS-CoV-2 viral replication in a dose-dependent manner. Conclusion(s): Our data demonstrate that the RBD could directly bind to platelets partially via beta3 integrin. RBD-induced platelet activation and clearance may contribute to thrombosis and thrombocytopenia observed in clinical cases of COVID-19 and VITT.